authors
- Hay, Annette E
- Murugesan, Alli
- DiPasquale, Ashley M
- Kouroukis, Tom
- Sandhu, Irwindeep
- Kukreti, Vishal
- Bahlis, Nizar J
- Lategan, Johan
- Reece, Donna E
- Lyons, John F
- Sederias, Joana
- Powers, Jean
- Xu, Hao
- Seymour, Lesley K
- Reiman, Anthony
A Phase II Study of AT9283, an Aurora Kinase Inhibitor, in Patients with Relapased or Refractory Multiple Myloma; NCIC Clinical Trials Group IND. 191
Conference Paper
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- December 6, 2014
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1114 Paediatrics and Reproductive Medicine (FoR)
- Immunology (Science Metrix)
published in
- Blood Journal